Filter posts

ALS Ice Bucket Challenge Brings Attention to the Need For Private Funding

The ALS Ice Bucket Challenge – the social media phenomenon in which people post videos …

WSJ Editorial: The Medical Innovation Threat

An editorial in today’s Wall Street Journal looks at the rising threat the American insurance industry’s …

Promising vaccine companies set to take the stage at BIO Investor Forum

It is no secret that vaccines are a hot space in biotech right now, and …

AP: Groups Claim Insurance Discrimination

In this August 18 article, Ricardo Alonso-Zaldivar highlights assertions by patient groups that new insurance …

Docs to FDA: Biosimilars should have different names than branded drugs

Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists …

National Immunization Awareness Month

August is National Immunization Awareness Month, providing a reminder of the importance of proper vaccination …

Seattle Times Commentary: New Approaches Needed to Fight Ebola

In the Seattle Times this week, BIO Ventures for Global Health President Jennifer Dent offered …

BIO Presents at 2014 Biological Weapons Convention Meeting of Experts

Last week marked the annual Biological Weapons Convention (BWC) Meeting of Experts in Geneva. The …

Forbes: Faster FDA Approvals Have Not Caused More Drug Safety Problems

In 1992, Congress, industry, and the FDA worked together to create the Prescription Drug User Fee …

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the …